The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
TiterVac IBRThis page contains information on TiterVac IBR for veterinary use.
The information provided typically includes the following:
- TiterVac IBR Indications
- Warnings and cautions for TiterVac IBR
- Direction and dosage information for TiterVac IBR
TiterVac IBRThis treatment applies to the following species:
Bovine Rhinotracheitis Vaccine
Modified Live Virus
TiterVac IBR Indications
For the vaccination of healthy cattle as an aid in the prevention of disease caused by bovine rhinotracheitis virus (IBR).
DIRECTIONS AND DOSAGE: Rehydrate the desiccated vial with accompanying diluent and shake well. Inject 2 mL subcutaneously or intramuscularly using aseptic technique. Annual revaccination is recommended. Calves vaccinated before weaning should be revaccinated 30 days after weaning when the possible influence of maternal antibodies is decreased.
TiterVac IBR Caution
Store at 35° to 45° F (2° to 7° C). DO NOT FREEZE. Use entire contents when first rehydrated. Allergic reactions may follow the use of vaccines. ANTIDOTE: Epinephrine. Do not vaccinate within 21 days before slaughter. Burn container and all unused contents.
DO NOT USE IN PREGNANT COWS OR IN CALVES NURSING PREGNANT COWS. ABORTIONS MAY RESULT.
FOR USE IN ANIMALS ONLY
Manufactured by: Diamond Animal Health, Inc., Des Moines, Iowa 50327 USA
US Veterinary License No. 213
Distributed by: Aspen Veterinary Resources,® Ltd., Liberty, MO 64068 USA
TiterVac is a registered trademark of Aspen Veterinary Resources,® Ltd.
NAC No.: 14751750
3155 W. HEARTLAND DRIVE, LIBERTY, MO, 64068
|Every effort has been made to ensure the accuracy of the TiterVac IBR information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-03-29